Biotechnology, Pharmaceutical & Life Sciences IP Litigation
Our Biotechnology, Pharmaceutical & Life Sciences IP Litigation Team has decades of litigation experience with Hatch–Waxman and biosimilars, biotechnology and medical devices, animal health, health supplements, and everything in between. We integrate our extensive litigation, regulatory, and business capabilities in this dynamic space to meet and exceed your specific, business-driven objectives.
JBLegal’s Biotechnology, Pharmaceutical & Life Sciences IP Litigation Team has over three decades of experience representing clients in U.S. district courts, the Federal Circuit, the Patent Trial and Appeal Board (PTAB), and the International Trade Commission (ITC). Our attorneys combine deep technical expertise in molecular biology, pharmaceutical and biomedical engineering, polymer science, and chemistry with strategic litigation skills to protect and enforce intellectual property rights.
We handle all aspects of IP disputes, including bench and jury trials, inter partes and post-grant reviews, parallel litigation, and ITC investigations, while collaborating closely with clients to achieve leverage and favorable resolutions aligned with business objectives.